Our research

Aims

  • To understand the genetic and environmental factors that predispose to cancer development in children and young people.
  • To describe the patterns of incidence of these cancers.
  • To understand the personal, psychological and social challenges faced by young people with cancer.
  • To identify genetic alterations characteristic of individual cancer types and to understand their biological roles.
  • To investigate the utility of disease biomarkers.
  • To shift treatment toward more targeted therapy.

Research groupings

The Centre has a number of research groupings lead by individual academics. These include:

Genetic epidemiology of childhood cancer

Research Leads: Professor Jill Birch and Dr Pam Thompson

Areas of research

  • Genetic predisposition to rhabdomyocarcoma
  • Genome wide associate study of hepatoblastoma
  • Molecular epidemiology of Wilm's tumour
  • P53-related early onset breast cancer
  • Analysis of haplotypes and meiotic recombination rates in childhood ALL
  • Investigating the role of PRDM9 in childhood leukaemia
  • Identification of rare genetic variants altering susceptibility to childhood ALL
See: Genetic epidemiology of childhood cancer for more information.

Mechanisms of drug resistance in childhood leukaemia and solid tumours

Research Leads: Professor Vaskar Saha and Dr Guy Makin

Areas of research

  • Identifying novel mechanisms of drug resistance (including hypoxia)
  • Better in vitro models of childhood cancer
  • Cellular therapy for resistant solid tumours
  • Investigating circulating tumour cells in sarcomas
See: Mechanisms of drug resistance in childhood leukaemia and solid tumours for more information.

DNA damage repair in Fanconi Anaemia

Research Lead: Dr Stefan Meyer

Areas of research

  • Understanding EVI1 function in Fanconic anaemia and FA-associated AML
  • Investigating the regulation of the DNA damage response in FA-derived AML cell lines
See: DNA damage repair in Fanconi Anaemia for more information.

Genetics, biology and improved therapeutics for childhood brain tumours

Research Leads: Dr Martin McCabe and Dr John-Paul Kilday

Areas of research

  • The role of isodicentric chromosome 17 in medulloblastoma
  • Genetics of ependymoma
  • Novel prognostic markers in ependymoma
  • Novel therapeutic targets in ependymoma
See: Genetics, biology and improved therapeutics for childhood brain tumours for more information.

Novel therapeutic approaches to childhood leukaemia and solid tumours

Research Leads: Professor Vaskar Saha, Dr Guy Makin and Dr Martin McCabe

Areas of research

  • Improving collaboration in clinical trials
  • Developing leukaemia treatment in resource poor countries
  • Leading the European study for relapsed Ewing's sarcoma (reeCUR)
  • Early phase clinical trials
See: Novel therapeutic approaches to childhood leukaemia and solid tumours for more information

 

Psychosocial consequences of treatment for cancer in children, teenagers and young adults

Research Leads: Dr Martin McCabe and Dr Guy Makin

Areas of research

  • Psychological short and long term effects of treatment
  • Psychological interventions to reduce treatment-related distress
See: Psychosocial consequences of treatment for cancer in children, teenagers and young adults